Palatin Technologies (PTN) Stock Price

Palatin Technologies Price

NYSE AMEX·CLOSED
5.70
​
Market closed

Revenue at Palatin Technologies has contracted by 0.5% per year over the past 19 years to 13.19 M USD. Palatin Technologies's net margin stands at -63.5%, down from 17,799.2% several years earlier. Analysts set a median price target of 7.14 USD, implying 25.3% above the current price. Of 5 analysts, 4 rate the stock a buy — an overall Buy consensus.

Palatin Technologies stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Palatin Technologies business model & stock analysis

Palatin Technologies Inc., based in Cranbury, New Jersey, is a biopharmaceutical company focused on developing receptor-specific therapeutics targeting unmet medical needs. The company specializes in molecules that modulate melanocortin and natriuretic peptide receptor systems, aiming to treat conditions such as cardiovascular diseases, fibrotic disorders, and metabolic issues. With 20 employees, it operates within the Health Care sector, listed on the market since 1999.

Frequently asked questions about Palatin Technologies

Analysts currently set an average price target of 7.14 USD for the Palatin Technologies stock (median: 7.14 USD), implying +25.3 % versus the latest price. The consensus is based on 5 analyst ratings.

7 analysts currently rate the Palatin Technologies stock: 6 recommend buying, 1 holding and 0 selling.

Converted at the current exchange rate, the Palatin Technologies share trades at 5.08 EUR (5.70 USD).

The Palatin Technologies share (PTN) is listed on 6 stock exchanges, including: London (0KF3.L), SIX (Zürich) (PTNA.SW), Frankfurt (PTNA.F), München (PTNA.MU), Düsseldorf (PTNA.DU).

The revenue of Palatin Technologies is 13.19 M USD. This figure is based on current financial data and reflects the company's business performance.

The profit of Palatin Technologies is -8.38 M USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Palatin Technologies is currently -1.92. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Palatin Technologies stock.

The price-to-sales ratio (P/S) of Palatin Technologies is currently 1.22. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Palatin Technologies stock.

The Eulerpool Quality Score for Palatin Technologies is 3/10.

The ISIN of Palatin Technologies is US6960776010. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Palatin Technologies is A1C538. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Palatin Technologies is PTN. The ticker symbol is used to trade Palatin Technologies shares on the stock exchange.

Fair ValueTerminal
5.87 USD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Biotechnology
Number of shares
Employees
Revenue per Employee
659,251.55 USD
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website palatin.com
Currency
USD
Initial public offering
Dec 21, 1999
ISIN
US6960776010
Cusip
696077403
Sedol
2103781
Market capitalization
3.07 M USDMicro Cap
52-Week Range
PEG
-0.11
P/E ratio
P/Ee 2027
-14.82
P/Ee 2028
-12.45
P/Ee 2029
-7.74
P/Ee 2030
-7.93
P/S
P/Se
1.47
EV/EBIT
0.48
P/B Ratio
0.46
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-121.24 %
Last updated Oct 23, 2026, 9:41 AM

Palatin Technologies Ticker

AMEX · PTNDÜSSELDORF · PTNA.DUFRANKFURT · PTNA.FLONDON · 0KF3.LMUNICH · PTNA.MUSIX · PTNA.SW